HEALTH TECHNOLOGY

MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities

Lyniate and MedAllies | August 22, 2022 | Read time : 02:00 min

MedAllies Selects

Lyniate, a global leader in healthcare data interoperability,  announced MedAllies, a leading multimodality connectivity services company, has chosen Lyniate Enterprise Master Patient Index (EMPI) by NextGate to better serve its healthcare clients and partners. This integration will bolster MedAllies’ identity data management capabilities to increase the accuracy of the data it exchanges for the benefit of all.

As the healthcare industry continues to shift toward a more consumer-centric approach to interoperability, MedAllies maintains its commitment to providing connectivity services to thousands of healthcare providers and organizations across the country. The company turned to Lyniate for its proven identity management solutions and unparalleled approach to facilitating real-time data exchange.

MedAllies realized the pressing need to invest in EMPI technology, and we are excited to partner and provide solutions that will strengthen the company’s data exchange services. MedAllies understands the need to ensure the data it helps customers exchange is accurate so as not to negatively impact care, and recognizes that more accurate data can better support MedAllies’ own strategic initiatives. We applaud MedAllies for prioritizing this investment and having the vision to bring this crucial capability to its customers.”

Scott Galbari, president and COO of Lyniate

Lyniate EMPI has the flexibility to support on-premises and cloud deployments with the ability to adapt and scale over time. It offers options for resolution of data issues using referential data as well as manual data remediation. Beyond its proven technology, Lyniate offers a world-class, hands-on approach to customer support and training to ensure its clients maximize their investment in patient data accuracy.

“Our clients and partners have spoken clearly: They need identity data solutions to be confident in the accuracy of the data that powers their businesses,” said Tom Visotsky, chief commercial officer at MedAllies. “After a great deal of due diligence, we came to the conclusion that Lyniate offers the most mature and robust EMPI solution on the market. We are excited to bring this powerful capability to meet our clients’ needs, fortify our care quality offering, and help our partners to thrive in a data-driven and consumer-focused healthcare environment.”

About Lyniate
Lyniate partners with healthcare organizations around the globe delivering a flexible interoperability suite that reliably connects people and the quality data they need. As a trusted partner, Lyniate powers the applications and workflows that improve clinical, operational, and financial outcomes today while helping healthcare teams to understand, prepare for, and influence changes on the horizon. Lyniate is committed to empowering people with Best-in-KLAS® ranking interoperability solutions for healthcare, from specialty clinics to large care networks, from health insurance providers to health technology, and everything in between. 

About MedAllies
MedAllies securely delivers vital health information to impact care by operating multiple national networks supporting interoperability for all healthcare constituents. We are focused on network and service excellence for individuals, connections, and participants accessing our Connectivity Services. We serve more than 700 hospitals, 5,000 organizations, 100,000 providers, and dozens of partners bringing together millions for a more fluid healthcare experience. 

Spotlight

Public Health England (PHE) was set up on 1 April 2013 as an operationally autonomous executive agency of the Department of Health. Our mission is to protect and improve the nation’s health and to address inequalities through working with national and local government, the NHS, industry and the voluntary and community sector.

Spotlight

Public Health England (PHE) was set up on 1 April 2013 as an operationally autonomous executive agency of the Department of Health. Our mission is to protect and improve the nation’s health and to address inequalities through working with national and local government, the NHS, industry and the voluntary and community sector.

Related News

HEALTH TECHNOLOGY

Pure Health UAE Largest Healthcare Platform Signs a Deal With Equity Group Investments to Invest Half a Billion Dollars in a U.S. Healthcare Company

Pure Health | September 05, 2022

Alpha Dhabi Holding subsidiary, Pure Health, the largest integrated healthcare platform of the United Arab Emirates announced that it has entered into a definitive purchase agreement to acquire a minority equity investment in Ardent Health Services a leading U.S. healthcare provider based in Nashville, Tennessee, for a total investment of $500 million. The investment is subject to customary closing conditions and will be finalized after receipt of all necessary U.S. regulatory approvals. Ardent is the fourth largest privately held acute care hospital operator in the U.S., with 30 hospitals and more than 200 sites of care across six states, and approximately 26,000 employees. Pure Health would achieve a minority equity investment by purchasing an interest in Ardent from Equity Group Investments a Chicago-based private investment firm and majority owner of Ardent. As part of its investment, Pure Health would receive board observer rights but would not have a seat on Ardent’s board of directors. The investment does not include plans for either the expansion of Ardent’s physical footprint or collaboration between Ardent and Pure Health in the delivery of care. Equity Group Investments hosted a signing ceremony, which included Farhan Malik, CEO of Pure Health, Sam Zell, founder and chairman of EGI, and Marty Bonick, president and chief executive officer of Ardent. “One of EGI’s strengths is partnering with like-minded individuals with the experience and passion for how we approach investment opportunities. We look forward to developing a productive relationship with Pure Health as they continue to explore the various dynamics of the U.S. healthcare system,” Sam Zell Commenting on the major investment announcement, Farhan Malik said, “This landmark investment agreement marks a quantum leap for the UAE and the global healthcare industry.” “This is an exciting opportunity for Pure Health, as we continue to build relationships with leading U.S. healthcare providers to leverage the highest standards and best clinical practices to provide an unrivalled healthcare experience for patients in the UAE,” said Malik. “Ardent has a strong track record of delivering outstanding services across the United States, and we look forward to gaining additional knowledge to support our north star of advancing the science of longevity and unlocking time for humanity.” ABOUT PURE HEALTH Pure Health is an integrated healthcare solutions platform with a diversified portfolio of over 25 hospitals and more than 100 clinics offering 200+ specialties covering services from tertiary care to primary care; health insurance that covers over 2.5 million members; group procurement organization; over 150 laboratories; diagnostics services; rehab services; long term care; medical supplies; and health technology services. With more than 50 million annual clinical encounters and over 25,000 employee strength, the company provides healthcare services across the entire continuum of care. Pure Health is committed to enhancing longevity and helping people live longer, happier, and healthier lives. The company’s centers of excellence bring together clinical knowledge, process expertise, technology, and analytics to deliver outcome-focused, world-class quality across all channels of healthcare with a mandate to future-proof the healthcare system for a world of technological singularity. ABOUT EQUITY GROUP INVESTMENTS Equity Group Investments (EGI), founded by Sam Zell more than 50 years ago, has a long track record of building public and private businesses, including the origination and growth of multi-billion-dollar companies. EGI’s flexible capital and open investment mandate enable the firm to pursue opportunistic transactions across industries and geographies, throughout the capital structure, at any point in the economic cycle. EGI’s current portfolio includes investments in transportation and logistics, health care, manufacturing, agribusiness, energy, retail, waste and infrastructure, and real estate. ABOUT ARDENT HEALTH SERVICES Ardent Health Services invests in people, technology and communities. Through its subsidiaries, Ardent owns and operates 30 hospitals and more than 200 sites of care in six states with approximately 26,000 employees, including 1,200+ employed providers. With a focus on evidence-based practices to improve quality care and patient outcomes, four Ardent hospitals were named to Leapfrog’s Top Hospitals in 2021, and eight Ardent hospitals received a Leapfrog Hospital Safety Grade of A for Spring 2022. Based in Nashville, Tennessee, Ardent is owned by current and former members of Ardent’s management team; Equity Group Investments (EGI), a Chicago-based private investment firm; and Ventas, Inc.

Read More

DIGITAL HEALTHCARE

Commure Introduces New Model to Accelerate Transformation in Healthcare with CommureOS

Commure | November 14, 2022

To help healthcare organizations hurdle long-standing barriers to meaningful transformation and drive exponential innovation at scale, Commure, Inc. today introduced CommureOS, a revolutionary transformation platform purpose-built for healthcare, at HLTH 2022. CommureOS is designed to give healthcare organizations the power to synthesize and maximize their existing solutions as well as easily build and rapidly deploy intelligent workflows to enhance clinical, operational, and financial efficiency. By reconciling information through a single platform and facilitating easy and connected innovation, CommureOS enables hospitals and health systems to streamline their technology experience, empower their healthcare workforce, and enhance care delivery and outcomes. “For decades, health organizations have been pushed to innovate at near-impossible speeds to keep up with the industry’s rate of change — and have made remarkable strides despite it all, More than ever, they deserve a robust tech experience that ensures their progress can endure. Over the past five years, we’ve been quietly and responsibly building a new model of innovation with some of our nation’s biggest health systems — and today, we invite pioneering organizations to embark with us on a new era of healthcare transformation.” -Ashwini Zenooz, MD, CEO of Commure With CommureOS, healthcare organizations can more effectively and efficiently: Unlock and connect disparate data points and static insights across their technology ecosystem and make them actionable and helpful at the point of care. Create, test, and deploy new solutions to solve their unique challenges with modular and industry-native building blocks — turning months of development into hours of configuration. Reuse established clinical and non-clinical data connections and extend across multiple use cases and workflows to seamlessly scale innovation throughout their organization. At a time when hospitals and health systems across the country are grappling with rising burnout and attrition, Commure is steadfast in our commitment to empower the healthcare workforce by simplifying and optimizing the tasks they do and the workflows they use every day, By helping health organizations derive meaning from mountains of data and build connected solutions at scale, we can finally ensure that people — rather than technology — are at the heart of our healthcare ecosystem,said Abhijit Mitra, chief product and engineering officer at Commure. With CommureOS, leading health systems and hospitals have the tools and support to create or customize the organizational workflows they need with ease, enabling them to streamline traditionally manual and time-consuming tasks and cultivate a more dynamic experience for clinicians, staff, and care delivery teams. There’s a new generation of digital health innovators keeping health systems at the center of their own transformation journeys — and Commure is at the forefront, Migrating from point solutions to platform is essential for technology-driven transformation of the sector. By connecting the dots and driving exceptional experiences, Commure is advancing our collective pursuit of responsible and enduring innovation,said Hemant Taneja, CEO and managing director at General Catalyst and co-founder of Commure. About Commure Commure, Inc. is building the first operating system designed for healthcare. By connecting disparate datasets, surfacing meaningful insights, accelerating performance through a suite of intuitive applications, and enabling seamless innovation across the industry, we empower every person in the health ecosystem to deliver exceptional care. Commure’s original applications include solutions to improve staff safety, enhance clinical workflow, and bolster financial operations. Commure is partnering with health systems, payors, and digital innovators to build a vibrant health ecosystem together; currently, the company enables more than 160,000 clinicians and staff across more than 400 care facilities to advance care through collaboration.

Read More

FUTURE OF HEALTHCARE

Brain Navi Biotechnology Announced Partnership with Distributor, Medtreq Medical Equipment

Brain Navi Biotechnology Co., Ltd. | September 12, 2022

Brain Navi, the leading surgical robot manufacture in Taiwan, announced a strategic partnership with distributor, Medtreq Medical Equipment, to expand the distribution of the Surgical Navigation Robot, NaoTrac, throughout the region of GCC region, Jordan, Egypt plus other countries in the Middle East and Philippines, Indonesia, Malaysia, and Singapore which will be covered by Medtreq branch in Philippines. NaoTrac, a CE-certified and local government approval neurosurgical navigation robot from Brain Navi Biotechnology, is embedding dissimilar technology named SMART Technology which combining the machine vision and in-house algorithm to perform robot-assisted surgery, to streamline surgical procedures with real-time imaging and minimal invasive outcomes. "We are always scouting for the new technology to help as many people as we can. We have many neurosurgeons coming from Riyadh and some other territories keening and willing to learn more about this technology, and the NaoTrac from Brain Navi is one of them. We are always happy to partner with an innovative technology company," Sherif Bayoumy, the General Manager of Medtreq Medical Equipment The collaboration and partnership between Brain Navi and Medtreq enables greater innovative outcome in the Middle East neurosurgery, such as Saudi Arabia, UAE, Egypt, Jordan, and some of the other countries on progressing, to streamline the surgical procedure, improve the surgical accuracy and pass-on knowledge to shorten the learning curves. "We seek strategic partners that can accelerate Brain Navi's growth mission. This partnership is a significant step toward scaling our business and getting more robot-assisted neurosurgery into the world," said Jerry Chen, the CEO of Brian Navi Biotechnology. "The collaboration between Metreq and Brain Navi is looking positive because we share the same mission to innovate with technology to make the life bright. We truly believe that the collaboration between Brain Navi and Medtreq can maximum the value of both sides to bring the neurosurgery to the next level." About Metreq Medical Equipment Bahrain Medtreq Medical Equipment provides professional technical support and after-service to clients in the MENA region with a presence in Bahrain and GCC, Egypt, North Africa, Turkey, Europe, the United States (Medtreq Tenessee USA), and the Philippines, Singapore, Malaysia, and Indonesia. Medtreq is built on high values, principles, and social commitment to society and humanity. About Brain Navi Brain Navi Biotechnology is a leading Taiwanese surgical robotic company. We design and develop innovative navigation and robotic surgery technologies for surgeons to improve surgical accuracy. Brain Navi's exclusive Surface Mapping Auto-registration Technology (SMART) is a significant surgical robotic breakthrough that merges machine vision, robotics, and AI technology to achieve streamlined surgical procedures with real-time imaging and minimal invasive outcomes.

Read More